Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Obesity × Omeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Neoplasms 8 Breast Neoplasms 6 Lymphoma, B-Cell, Marginal Zone 4 Barrett Esophagus 4 Lymphoma, Large B-Cell, Diffuse 3 Inflammation 3 Head and Neck Neoplasms 3 Zollinger-Ellison Syndrome 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Stomach Ulcer 1 Solid Tumours 1 Solid Tumor 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Precancerous Gastric Lesions 1 Pharmacokinetics of MDV3100 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Obesity 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Exercise 22 Metformin 18 Methods 7 Diet Therapy 7 Diet 7 Tirzepatide 6 Resistance Training 6 Nutrition Assessment 6 Early Intervention, Educational 6 Counseling 6 Caloric Restriction 6 Exenatide 5 Educational Status 4 Docosahexaenoic Acids 4 Diet, Mediterranean 4 semaglutide 3 Vitamin D 3 Therapeutics 3 Standard of Care 3 Liraglutide 3 Dexamethasone 3 Yoga 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Specimen Handling 2 Ovidrel 2 Nutritional Status 2 Naltrexone 2 Mindfulness-Based Stress Reduction 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡